30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Natus Medical Inc (NTUS)

Track

Stock chart
Ticker: NTUS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CHUNG DONG CHUNE CHRISTOPHER
Chief Medical Officer
1 sale — total 272,044 USD
Sale 9 Dec 2021
Value US$2,987,495.30 | Price 32.56 | Shares 87,354
Sale 11 Jun 2021
Value US$1,401,759.00 | Price 118.22 | Shares 22,359
Sale 11 Jun 2021
Value US$80,655.66 | Price 27.49 | Shares 2,934
Sale 25 May 2021
Value US$258,613.35 | Price 27.41 | Shares 9,435
Sale 24 May 2021
Value US$542,200.00 | Price 27.11 | Shares 20,000
Sale 20 May 2021
Value US$250,830.00 | Price 27.00 | Shares 9,290
Sale 19 May 2021
Value US$168,980.18 | Price 26.54 | Shares 6,367
Sale 18 May 2021
Value US$78,117.60 | Price 26.90 | Shares 2,904
Sale 14 May 2021
Value US$620,753.37 | Price 28.31 | Shares 21,927
Sale 13 May 2021
Value US$775,079.16 | Price 27.96 | Shares 27,721
Sale 12 May 2021
Value US$277,666.76 | Price 27.47 | Shares 10,108
Sale 7 Aug 2020
Value US$21,636.00 | Price 18.03 | Shares 1,200
Sale 6 Dec 2019
Value US$210,813.36 | Price 31.54 | Shares 6,684
Sale 5 Nov 2019
Value US$146,477.76 | Price 34.32 | Shares 4,268
Sale 4 Nov 2019
Value US$148,329.20 | Price 33.65 | Shares 4,408
Sale 30 Oct 2019
Value US$469,980.00 | Price 33.57 | Shares 14,000
Sale 1 Aug 2019
Value US$403,466.08 | Price 31.94 | Shares 12,632
Sale 31 Jul 2019
Value US$622,800.00 | Price 31.14 | Shares 20,000
Sale 11 Jun 2019
Value US$103,742.50 | Price 24.41 | Shares 4,250
Sale 31 May 2019
Value US$149,040.00 | Price 24.84 | Shares 6,000
Sale 21 May 2019
Value US$13,320.00 | Price 26.64 | Shares 500
Sale 17 May 2019
Value US$78,840.00 | Price 26.28 | Shares 3,000
Sale 10 May 2019
Value US$197,494.20 | Price 26.28 | Shares 7,515
Sale 2 May 2019
Value US$53,840.00 | Price 26.92 | Shares 2,000
Sale 1 May 2019
Value US$107,520.00 | Price 26.88 | Shares 4,000
Sale 30 Apr 2019
Value US$376,627.50 | Price 26.43 | Shares 14,250
Sale 30 Apr 2019
Value US$52,500.00 | Price 26.25 | Shares 2,000
Buy 7 Mar 2019
Value US$2,718.00 | Price 27.18 | Shares 100
Sale 4 Mar 2019
Value US$57,000.00 | Price 28.50 | Shares 2,000
Sale 1 Mar 2019
Value US$56,600.00 | Price 28.30 | Shares 2,000
Sale 1 Mar 2019
Value US$119,651.20 | Price 27.80 | Shares 4,304
Sale 25 Feb 2019
Value US$104,744.64 | Price 28.34 | Shares 3,696
Sale 29 Nov 2018
Value US$349,300.00 | Price 34.93 | Shares 10,000
Sale 19 Nov 2018
Value US$494,715.00 | Price 33.54 | Shares 14,750
Sale 26 Oct 2018
Value US$581,200.00 | Price 29.06 | Shares 20,000
Sale 30 Aug 2018
Value US$148,790.88 | Price 36.54 | Shares 4,072
Sale 29 Aug 2018
Value US$450,283.68 | Price 36.96 | Shares 12,183
Sale 29 Aug 2018
Value US$1,155,063.25 | Price 36.85 | Shares 31,345
Sale 2 Aug 2018
Value US$110,670.00 | Price 36.89 | Shares 3,000
Sale 2 Aug 2018
Value US$184,450.00 | Price 36.89 | Shares 5,000
Sale 31 Jul 2018
Value US$18,025.00 | Price 36.05 | Shares 500
Sale 31 Jul 2018
Value US$116,640.00 | Price 36.00 | Shares 3,240
Sale 27 Jul 2018
Value US$139,523.00 | Price 34.03 | Shares 4,100
Sale 27 Jul 2018
Value US$170,850.00 | Price 34.17 | Shares 5,000
Sale 16 May 2018
Value US$107,730.00 | Price 35.91 | Shares 3,000
Sale 16 May 2018
Value US$179,550.00 | Price 35.91 | Shares 5,000
Sale 9 May 2018
Value US$315,937.50 | Price 33.70 | Shares 9,375
Sale 7 May 2018
Value US$511,728.56 | Price 33.32 | Shares 15,358
Sale 30 Apr 2018
Value US$1,190,408.01 | Price 33.37 | Shares 35,673
Sale 30 Apr 2018
Value US$2,574,472.77 | Price 33.51 | Shares 76,827
Sale 30 Apr 2018
Value US$1,589,825.00 | Price 33.47 | Shares 47,500
Sale 2 Mar 2018
Value US$126,700.00 | Price 31.68 | Shares 4,000
Sale 13 Nov 2017
Value US$205,050.00 | Price 41.01 | Shares 5,000
Sale 6 Nov 2017
Value US$542,468.22 | Price 42.91 | Shares 12,642
Sale 14 Sep 2017
Value US$154,748.00 | Price 35.17 | Shares 4,400
Sale 14 Aug 2017
Value US$102,300.00 | Price 34.10 | Shares 3,000
Buy 15 Jun 2017
Value US$135,900.00 | Price 33.98 | Shares 4,000
Planned buy 31 May 2017
Value US$202,860.00 | Price 33.81 | Shares 6,000
Sale 25 May 2017
Value US$163,400.00 | Price 32.68 | Shares 5,000
Sale 2 Mar 2017
Value US$186,300.00 | Price 37.26 | Shares 5,000
Sale 9 Feb 2017
Value US$180,000.00 | Price 36.00 | Shares 5,000
Buy 16 Dec 2016
Value US$352,000.00 | Price 35.20 | Shares 10,000
Buy 27 Oct 2016
Value US$383,030.00 | Price 38.30 | Shares 10,000
Sale 25 Oct 2016
Value US$665,153.49 | Price 41.22 | Shares 16,138
Sale 24 Oct 2016
Value US$588,225.63 | Price 41.61 | Shares 14,138
Sale 24 Oct 2016
Value US$136,237.40 | Price 41.92 | Shares 3,250
Buy 28 Sep 2016
Value US$384,840.00 | Price 38.48 | Shares 10,000
Sale 26 Apr 2016
Value US$173,050.00 | Price 34.61 | Shares 5,000
Sale 22 Apr 2016
Value US$163,400.00 | Price 32.68 | Shares 5,000
Sale 22 Apr 2016
Value US$250,324.04 | Price 33.56 | Shares 7,459
Sale 17 Feb 2016
Value US$3,861.00 | Price 33.00 | Shares 117
Sale 16 Feb 2016
Value US$214,894.16 | Price 33.02 | Shares 6,508
Sale 9 Dec 2015
Value US$682,920.00 | Price 48.78 | Shares 14,000
Sale 27 Nov 2015
Value US$2,134,371.36 | Price 49.17 | Shares 43,408
Sale 25 Nov 2015
Value US$1,052,700.00 | Price 48.40 | Shares 21,750
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-13 2021-12-09 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

Chief Medical Officer

Officer
87,354 +28.4%
32.56
US$2,987,495 		87,354 +28.4% 32.56 US$2,987,495
2021-06-15 2021-06-11 S Sale
1.1
Daskal Ilan
Non-Executive Director
22,359 -20.6%
118.22
US$1,401,759 		22,359 -20.6% 118.22 US$1,401,759
2021-06-15 2021-06-11 S Sale
2.8
SCHROEDER ALICE D.
Non-Executive Director
4,816 -3.2%
474.97
US$3,182,046 		4,816 -3.2% 474.97 US$3,182,046
2021-05-26 2021-05-25 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
9,435 -12.9%
27.41
US$258,613 		9,435 -12.9% 27.41 US$258,613
2021-05-26 2021-05-24 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
20,000 -21.5%
27.11
US$542,200 		20,000 -21.5% 27.11 US$542,200
2021-05-20 2021-05-20 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
9,290 -9.1%
27.00
US$250,830 		9,290 -9.1% 27.00 US$250,830
2021-05-20 2021-05-19 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
6,367 -5.9%
26.54
US$168,980 		6,367 -5.9% 26.54 US$168,980
2021-05-20 2021-05-18 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
2,904 -2.6%
26.90
US$78,118 		2,904 -2.6% 26.90 US$78,118
2021-05-14 2021-05-14 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
21,927 -16.4%
28.31
US$620,753 		21,927 -16.4% 28.31 US$620,753
2021-05-14 2021-05-13 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
27,721 -17.2%
27.96
US$775,079 		27,721 -17.2% 27.96 US$775,079
2021-05-14 2021-05-12 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
10,108 -5.9%
27.47
US$277,667 		10,108 -5.9% 27.47 US$277,667
2020-08-10 2020-08-07 S Sale
2.3
Heine Lisa Wipperman
Non-Executive Director
1,200 -7.0%
18.03
US$21,636 		1,200 -7.0% 18.03 US$21,636
2019-12-09 2019-12-06 S Sale Kennedy Jonathan

President and CEO

Executive Director
6,684 -4.5%
31.54
US$210,813 		6,684 -4.5% 31.54 US$210,813
2019-11-06 2019-11-05 S Sale Kennedy Jonathan

President and CEO

Executive Director
4,268 -2.9%
34.32
US$146,478 		4,268 -2.9% 34.32 US$146,478
2019-11-06 2019-11-04 S Sale Kennedy Jonathan

President and CEO

Executive Director
4,408 -3.1%
33.65
US$148,329 		4,408 -3.1% 33.65 US$148,329
2019-11-01 2019-10-30 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs
14,000 -8.5%
33.57
US$469,980 		14,000 -8.5% 33.57 US$469,980
2019-08-02 2019-08-01 S Sale LUDLUM KEN Non-Executive Director
12,632 -24.3%
31.94
US$403,466 		12,632 -24.3% 31.94 US$403,466
2019-08-02 2019-07-31 S Sale Noll Austin Francis III

Executive VP and CCO

Officer
20,000 -19.0%
31.14
US$622,800 		20,000 -19.0% 31.14 US$622,800
2019-06-13 2019-06-11 S Sale
1.4
LUDLUM KEN
4,250 -8.4%
24.41
US$103,742 		4,250 -8.4% 24.41 US$103,742
2019-06-04 2019-05-31 S Sale
1.4
LUDLUM KEN
6,000 -10.6%
24.84
US$149,040 		6,000 -10.6% 24.84 US$149,040
2019-05-21 2019-05-21 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
500 -0.3%
26.64
US$13,320 		500 -0.3% 26.64 US$13,320
2019-05-21 2019-05-17 S Sale
3.2
CHUNG DONG CHUNE CHRISTOPHER

VP of Medical Affairs

Officer
3,000 -1.9%
26.28
US$78,840 		3,000 -1.9% 26.28 US$78,840
2019-05-13 2019-05-10 S Sale
1.4
LUDLUM KEN
Non-Executive Director
7,515 -11.8%
26.28
US$197,494 		7,515 -11.8% 26.28 US$197,494
2019-05-02 2019-05-02 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
2,000 -8.9%
26.92
US$53,840 		2,000 -8.9% 26.92 US$53,840
2019-05-02 2019-05-01 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
4,000 -15.2%
26.88
US$107,520 		4,000 -15.2% 26.88 US$107,520
2019-05-02 2019-04-30 S Sale
1.6
Noll Austin Francis III

Executive VP and CCO
14,250 -14.3%
26.43
US$376,628 		14,250 -14.3% 26.43 US$376,628
2019-05-02 2019-04-30 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
2,000 -7.0%
26.25
US$52,500 		2,000 -7.0% 26.25 US$52,500
2019-03-11 2019-03-07 B Purchase
2.3
Heine Lisa Wipperman
100 +2.4%
27.18
US$2,718 		100 +2.4% 27.18 US$2,718
2019-03-05 2019-03-04 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
2,000 -6.6%
28.50
US$57,000 		2,000 -6.6% 28.50 US$57,000
2019-03-05 2019-03-01 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
2,000 -6.2%
28.30
US$56,600 		2,000 -6.2% 28.30 US$56,600
2019-03-05 2019-03-01 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
4,304 -11.7%
27.80
US$119,651 		4,304 -11.7% 27.80 US$119,651
2019-02-26 2019-02-25 S Sale
3.1
GUNST ROBERT A
Non-Executive Director
3,696 -9.2%
28.34
US$104,745 		3,696 -9.2% 28.34 US$104,745
2018-12-03 2018-11-29 S Sale LUDLUM KEN Non-Executive Director
10,000 -13.5%
34.93
US$349,300 		10,000 -13.5% 34.93 US$349,300
2018-11-20 2018-11-19 S Sale GUNST ROBERT A Non-Executive Director
14,750 -31.3%
33.54
US$494,715 		14,750 -31.3% 33.54 US$494,715
2018-12-03 2018-10-26 S Sale LUDLUM KEN Non-Executive Director
20,000 -21.3%
29.06
US$581,200 		20,000 -21.3% 29.06 US$581,200
2018-08-31 2018-08-30 S Sale Kennedy Jonathan

President and CEO

Executive Director
4,072 -3.4%
36.54
US$148,791 		4,072 -3.4% 36.54 US$148,791
2018-08-31 2018-08-29 S Sale Kennedy Jonathan

President and CEO

Executive Director
12,183 -9.4%
36.96
US$450,284 		12,183 -9.4% 36.96 US$450,284
2018-08-31 2018-08-29 S Sale Kennedy Jonathan

President and CEO

Executive Director
31,345 -19.4%
36.85
US$1,155,063 		31,345 -19.4% 36.85 US$1,155,063
2018-08-06 2018-08-02 S Sale LUDLUM KEN Non-Executive Director
3,000 -3.1%
36.89
US$110,670 		3,000 -3.1% 36.89 US$110,670
2018-08-06 2018-08-02 S Sale LUDLUM KEN Non-Executive Director
5,000 -5.1%
36.89
US$184,450 		5,000 -5.1% 36.89 US$184,450
2018-07-31 2018-07-31 S Sale GUNST ROBERT A Non-Executive Director
500 -1.0%
36.05
US$18,025 		500 -1.0% 36.05 US$18,025
2018-07-31 2018-07-31 S Sale GUNST ROBERT A Non-Executive Director
3,240 -6.4%
36.00
US$116,640 		3,240 -6.4% 36.00 US$116,640
2018-07-31 2018-07-27 S Sale GUNST ROBERT A Non-Executive Director
4,100 -7.5%
34.03
US$139,523 		4,100 -7.5% 34.03 US$139,523
2018-07-31 2018-07-27 S Sale GUNST ROBERT A Non-Executive Director
5,000 -8.3%
34.17
US$170,850 		5,000 -8.3% 34.17 US$170,850
2018-05-18 2018-05-16 S Sale MOORE WILLIAM M Non-Executive Director
3,000 -3.2%
35.91
US$107,730 		3,000 -3.2% 35.91 US$107,730
2018-05-18 2018-05-16 S Sale MOORE WILLIAM M Non-Executive Director
5,000 -5.3%
35.91
US$179,550 		5,000 -5.3% 35.91 US$179,550
2018-05-11 2018-05-09 S Sale Noll Austin Francis III

VP/GM Neurology

Officer
9,375 -10.3%
33.70
US$315,938 		9,375 -10.3% 33.70 US$315,938
2018-05-09 2018-05-07 S Sale CHUNG DONG CHUNE CHRISTOPHER

Vice President Medical Affairs

Officer
15,358 -10.1%
33.32
US$511,729 		15,358 -10.1% 33.32 US$511,729
2018-05-02 2018-04-30 S Sale HAWKINS JAMES B

President and CEO

Executive Director
35,673 -5.3%
33.37
US$1,190,408 		35,673 -5.3% 33.37 US$1,190,408
2018-05-02 2018-04-30 S Sale HAWKINS JAMES B

President and CEO

Executive Director
76,827 -10.7%
33.51
US$2,574,473 		76,827 -10.7% 33.51 US$2,574,473
2018-05-02 2018-04-30 S Sale HAWKINS JAMES B

President and CEO

Executive Director
47,500 -6.9%
33.47
US$1,589,825 		47,500 -6.9% 33.47 US$1,589,825
2018-03-06 2018-03-02 S Sale LUDLUM KEN
4,000 -4.3%
31.68
US$126,700 		4,000 -4.3% 31.68 US$126,700
2017-11-15 2017-11-13 S Sale MOORE WILLIAM M
5,000 -5.3%
41.01
US$205,050 		5,000 -5.3% 41.01 US$205,050
2017-11-08 2017-11-06 S Sale CHUNG DONG CHUNE CHRISTOPHER

Vice President Medical Affairs
12,642 -8.9%
42.91
US$542,468 		12,642 -8.9% 42.91 US$542,468
2017-09-15 2017-09-14 S Sale GUNST ROBERT A
4,400 -8.0%
35.17
US$154,748 		4,400 -8.0% 35.17 US$154,748
2017-08-15 2017-08-14 S Sale MOORE WILLIAM M
3,000 -3.1%
34.10
US$102,300 		3,000 -3.1% 34.10 US$102,300
2017-06-15 2017-06-15 B Purchase HAWKINS JAMES B

President and CEO

Executive Director
4,000 +0.7%
33.98
US$135,900 		4,000 +0.7% 33.98 US$135,900
2017-05-31 2017-05-31 PP Planned purchase HAWKINS JAMES B

President and CEO

Executive Director
6,000 +1.1%
33.81
US$202,860 		6,000 +1.1% 33.81 US$202,860
2017-05-30 2017-05-25 S Sale Engibous Doris Non-Executive Director
5,000 -22.1%
32.68
US$163,400 		5,000 -22.1% 32.68 US$163,400
2017-03-06 2017-03-02 S Sale MOORE WILLIAM M Non-Executive Director
5,000 -5.1%
37.26
US$186,300 		5,000 -5.1% 37.26 US$186,300
2017-02-10 2017-02-09 S Sale GUNST ROBERT A Non-Executive Director
5,000 -8.9%
36.00
US$180,000 		5,000 -8.9% 36.00 US$180,000
2016-12-16 2016-12-16 B Purchase HAWKINS JAMES B

President and CEO

Executive Director
10,000 +2.1%
35.20
US$352,000 		10,000 +2.1% 35.20 US$352,000
2016-10-27 2016-10-27 B Purchase HAWKINS JAMES B

President and CEO

Executive Director
10,000 +2.2%
38.30
US$383,030 		10,000 +2.2% 38.30 US$383,030
2016-10-26 2016-10-25 S Sale Kennedy Jonathan

Sr. VP, CFO

Executive Director
16,138 -18.5%
41.22
US$665,153 		16,138 -18.5% 41.22 US$665,153
2016-10-26 2016-10-24 S Sale Kennedy Jonathan

Sr. VP, CFO

Executive Director
14,138 -15.5%
41.61
US$588,226 		14,138 -15.5% 41.61 US$588,226
2016-10-24 2016-10-24 S Sale GUNST ROBERT A Non-Executive Director
3,250 -6.0%
41.92
US$136,237 		3,250 -6.0% 41.92 US$136,237
2016-09-28 2016-09-28 B Purchase HAWKINS JAMES B

President and CEO

Executive Director
10,000 +2.2%
38.48
US$384,840 		10,000 +2.2% 38.48 US$384,840
2016-04-28 2016-04-26 S Sale GUNST ROBERT A Non-Executive Director
5,000 -9.1%
34.61
US$173,050 		5,000 -9.1% 34.61 US$173,050
2016-04-26 2016-04-22 S Sale Engibous Doris Non-Executive Director
5,000 -27.4%
32.68
US$163,400 		5,000 -27.4% 32.68 US$163,400
2016-04-26 2016-04-22 S Sale TRAVERSO KENNETH M

VP/GM Newborn Care

Officer
7,459 -6.7%
33.56
US$250,324 		7,459 -6.7% 33.56 US$250,324
2016-02-18 2016-02-17 S Sale LUDLUM KEN Non-Executive Director
117 -0.1%
33.00
US$3,861 		117 -0.1% 33.00 US$3,861
2016-02-18 2016-02-16 S Sale LUDLUM KEN Non-Executive Director
6,508 -7.5%
33.02
US$214,894 		6,508 -7.5% 33.02 US$214,894
2015-12-11 2015-12-09 S Sale CHUNG DONG CHUNE CHRISTOPHER

Vice President Medical Affairs

Officer
14,000 -10.2%
48.78
US$682,920 		14,000 -10.2% 48.78 US$682,920
2015-11-30 2015-11-27 S Sale HAWKINS JAMES B

President and CEO

Executive Director
43,408 -10.3%
49.17
US$2,134,371 		43,408 -10.3% 49.17 US$2,134,371
2015-11-30 2015-11-25 S Sale Noll Austin Francis III

VP/GM Neurology

Officer
21,750 -27.3%
48.40
US$1,052,700 		21,750 -27.3% 48.40 US$1,052,700
Explore more

More insider trading research around Natus Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America